7498 Results (Page 226 of 300)
Pharmaceuticals Markets Research Reports
Switzerland Pharmaceutical Market Analysis
This report presents a strategic analysis of the Switzerland Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Switzerland Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
South Korea Cancer Immunotherapy Market Analysis
South Korean cancer immunotherapy market is expected to grow from $1.64 Bn in 2022 to $3.06 Bn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The increase in the ageing population and the demand for new and innovative treatment options in South Korea have led to the growth of the market. The South Korean cancer immunotherapy market is segmented by type, application, and end user. Selecxine, Panolos Bioscience, and Bayer are the major players in the South Korean cancer immunotherapy market.
Saudi Arabia Diabetes Therapeutics Market Analysis
Saudi Arabia's diabetes therapeutics market is expected to witness growth from $2.4 Bn in 2022 to $5.7 Bn in 2030 with a CAGR of 11.2% for the forecasted year 2022-2030. The increase in the awareness of diabetes in Saudi Arabia and recent technological advancements in the treatment of diabetes has resulted in the expansion of the market. The Saudi Arabia diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Damman Pharma, Saudi Pharmaceutical, and Eli Lilly are the major players in the Saudi Arabia diabetes therapeutics market.
Saudi Arabia Dermatology Drugs Market Analysis
This report presents a strategic analysis of the Saudi Arabia Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Saudi Arabia Dermatology Drugs Market, offering unmatched value, accuracy and expert insights.
Qatar Dermatology Drugs Market Analysis
This report presents a strategic analysis of the Qatar Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Qatar Dermatology Drugs Market, offering unmatched value, accuracy and expert insights.
Portugal Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Portugal Dermatology drugs market will reach a value of $xx Mn from $51 Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Roche Portugal, Eurofarma, and Bial. The market is driven by teledermatology consultations, the prevalence of dermatological diseases, and awareness about dermatological health. The dermatology drug market in Portugal is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Philippines Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Philippines Dermatology drugs market will reach a value of $xx Mn from $37 Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Unilab, Mercury Drug Corporation, and Southstar Drug. The market is driven by medical tourism, awareness about dermatological health, and government regulations. The dermatology drug market in the Philippines is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Mexico Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico Lung Cancer Therapeutics Market will reach a value of $850 Mn from $447 Mn in 2022, growing at a CAGR of 8.4% during 2022-2030. The Lung Cancer Therapeutics Market in Mexico is dominated by a few domestic pharmaceutical companies such as Silanes, Liomont, and PISA. The Lung Cancer Therapeutics Market in Mexico is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Mexico lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Mexico Acne Drugs Market Analysis
This report presents a strategic analysis of the Mexico Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Mexico Acne Drugs Market, offering unmatched value, accuracy and expert insights.
Japan Diabetes Therapeutics Market Analysis
Japan's diabetes therapeutics market is expected to grow from $8.94 Bn in 2022 to $19.45 Bn in 2030 with a CAGR of 10.2% for the forecasted year 2022-30. The rise in the ageing population and obesity among the Japanese population is responsible for the growth of the market. The Japan diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Eisai, Otsuka Holdings, and Roche are the major players in the Japanese diabetes therapeutics market.
Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
Japan's Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics market is expected to grow from $230 Mn in 2022 to $519 Mn in 2030 with a CAGR of 10.70% for the year 2022-30. PNH has been on the rise in Japan over the past several years in terms of incidence and prevalence. As a result, there is now a considerable market opportunity for producers of PNH medicines. The market is segmented by therapy, diagnostic test, by distribution channel. Some key players in this market include Takeda Pharmaceutical, Astellas Pharma, Otsuka Pharmaceutical, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring and Bioverativ.
Global Dermatology Drugs Market Analysis
This report presents a strategic analysis of the Global Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Global Dermatology Drugs Market, offering unmatched value, accuracy and expert insights.
Finland Pharmaceutical Market Analysis
This report presents a strategic analysis of the Finland Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Finland Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Europe Anti-Depressants Drugs Market Analysis
Europe's Anti-Depressants drugs market size was valued at $3.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.64% from 2022 to 2030 and will reach $4.48 Bn in 2030. The market is segmented by drug class, indication, route of administration, end-user, distribution channel, and geography. The Europe Anti-Depressants drug market will grow because of the development of novel antidepressant drugs and the expansion of the product portfolio of pharmaceutical companies. The key market players are GlaxoSmithKline plc (GBR), AstraZeneca (GBR), Mallinckrodt (GBR), Novartis AG and others.
China Diabetes Therapeutics Market Analysis
China's diabetes therapeutics market is expected to grow from $11.56 Bn in 2022 to $27.04 Bn in 2030 with a CAGR of 11.2% for the forecasted year 2022-2030. The rise in the ageing population of China and the introduction of novel therapeutic options in China are the major growth drivers of the market. The China diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Yunnan Baiyao, Kangmei Pharmaceutical, and Eli Lilly are the major players in the China diabetes therapeutics market.
China Cancer Immunotherapy Market Analysis
China's cancer immunotherapy market is expected to grow from $9.04 Bn in 2022 to $17.50 Bn in 2030 with a CAGR of 8.6% for the forecasted year 2022-2030. A larger patient pool suffering from cancer in China and the increased funding from the Chinese government for R&D in cancer immunotherapy are driving the growth of the market. The China cancer immunotherapy market is segmented by type, application, and end user. BeiGene, Legend Biotech, and AstraZeneca are the major players in the China cancer immunotherapy market.
Canada Dermatology Prescription Market Analysis
Canada's dermatology prescription market is expected to grow from $459.7 Mn in 2022 to $927.4 Mn in 2030 with a CAGR of 9.2% for the year 2022-30. Rising incidences of dermatology disorders involving the skin, nails, hair, etc, and the demand for novel therapeutics for the treatment of dermatology disorders in Canada are major market drivers of the Canadian dermatology prescription market. the market is segmented by disease type, drug class, route of administration, end-user, and by distribution channel. Affinium, Pfizer, and Sanofi are some of the key players in Canada's dermatology prescription market.
Australia Cardiovascular Diseases Therapeutics Market Analysis
Australia's cardiovascular disease therapeutics market is expected to witness growth from $1.95 Bn in 2022 to $3.81 Bn in 2030 with a CAGR of 8.72% for the year 2022-2030. The rising prevalence of cardiovascular diseases and the demand for innovative therapeutic options for treatment in Australia is responsible for the expansion of the market. The Australian cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Folarix Pharmaceutical, Adelco Pharmaceuticals, and AstraZeneca are the major players in the Australian cardiovascular disease therapeutics market.
Algeria Antibacterial (Antibiotics) Drugs Market Analysis
This report presents a strategic analysis of the Algeria Antibacterial (Antibiotics) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Algeria Antibacterial (Antibiotics) Drugs Market, offering unmatched value, accuracy and expert insights.
APAC Dermatology Drugs Market Analysis
This report presents a strategic analysis of the APAC Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC Dermatology Drugs Market, offering unmatched value, accuracy and expert insights.
US ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The US ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $12.415 Bn in 2022 to $14.776 Bn by 2030, registering a CAGR of 2.20% during the forecast period of 2022-2030. The number of individuals diagnosed with ADHD is on the rise, leading to a higher demand for ADHD medications. Some of the key players in the US ADHD drugs market include Shire (now part of Takeda), Johnson & Johnson, Novartis, Pfizer, Eli Lilly and Company, Concert Pharmaceuticals, Aevi Genomic Medicine, Neos Therapeutics, Vayarin, Supernus Pharmaceuticals.
UK Cancer Immunotherapy Market Analysis
The UK cancer immunotherapy market is expected to grow from $2.9 Bn in 2022 to $4.3 Bn in 2030 with a CAGR of 5.1% for the forecasted year 2022-2030. The new scientific developments in cancer immunotherapies and growing awareness about immunotherapy options in the UK are responsible for the expansion of the market. The UK cancer immunotherapy market is segmented by type, application, and end user. Ervaxx, Immunocore, and Amgen are the major players in the UK cancer immunotherapy market.
UK Radiotherapy Market Analysis
By 2030, it is anticipated that the UK Radiotherapy Market will reach a value of $7.7 Bn from $4.7 Bn in 2022, growing at a CAGR of 6.4% during 2022-30. The Radiotherapy Therapeutics Market in the UK is dominated by a few domestic players such as Alpha Omega Services, Curium Pharma, and Oncology Systems Limited. The radiotherapy market in the UK is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for UK Radiotherapy is increasing on account of the rise in cancer cases in the country.
Spain Diabetes Therapeutics Market Analysis
Spain's diabetes therapeutics market is expected to grow from $2.77 Bn in 2022 to $5.41 Bn in 2030 with a CAGR of 8.7% for the forecasted year 2022-2030. The increasing prevalence of diabetes and the supportive government policies to promote diabetes-related research and development projects are responsible for the expansion of the market. The Spain diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Farmalider, Cenfarte, and Boehringer Ingelheim are the major players in the Spain diabetes therapeutics market.
Spain Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Spain Dermatology drugs market will reach a value of $693.15 Mn from $328.1 Mn in 2022, growing at a CAGR of 9.8% during 2022-2030. The market is primarily dominated by local players such as Infarco, Cantabria Labs, and Almirall. The market is driven by hefty manufacturing and development costs, increasing prevalence, and good health insurance. The dermatology drug market in Spain is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
